Short Interest in NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Drops By 95.0%

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) was the target of a large decline in short interest in December. As of December 15th, there was short interest totalling 900 shares, a decline of 95.0% from the November 30th total of 18,100 shares. Based on an average daily trading volume, of 23,300 shares, the days-to-cover ratio is currently 0.0 days.

NLS Pharmaceutics Stock Performance

NASDAQ:NLSPW traded down $0.01 during trading hours on Friday, reaching $0.01. The company had a trading volume of 13,555 shares, compared to its average volume of 21,356. NLS Pharmaceutics has a one year low of $0.01 and a one year high of $0.10. The stock has a 50-day moving average of $0.01 and a two-hundred day moving average of $0.02.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).